UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
WASHINGTON, D.C. 20549
______________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 17, 2013
BioMed Realty Trust, Inc.
(Exact name of registrant as specified in its charter)
Maryland | 1-32261 (BioMed Realty Trust, Inc.) | 20-1142292 (BioMed Realty Trust, Inc.) | ||
(State or other jurisdiction of | (Commission File No.) | (I.R.S. Employer Identification No.) | ||
incorporation or organization) | ||||
17190 Bernardo Center Drive
San Diego, California 92128
San Diego, California 92128
(Address of principal executive offices, including zip code)
Registrant’s telephone number, including area code: (858) 485-9840
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On December 17, 2013, the Board of Directors of BioMed Realty Trust, Inc. appointed Dr. William R. Brody to the Board, increasing the Board to nine members. A copy of the press release announcing Dr. Brody’s appointment is filed as Exhibit 99.1 hereto and incorporated herein by reference.
In connection with Dr. Brody’s appointment to the Board, he was granted 4,369 shares of restricted common stock under BioMed Realty’s 2004 Incentive Award Plan. The restricted stock was granted pursuant to the Form of Restricted Stock Award Grant Notice and Restricted Stock Award Agreement which is filed as Exhibit 10.1 hereto and incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) The following exhibits are filed herewith:
Exhibit | ||
Number | Description of Exhibit | |
10.1 | Form of Restricted Stock Award Grant Notice and Restricted Stock Award Agreement under the 2004 Incentive Award Plan.(1) | |
99.1 | Press release issued by BioMed Realty Trust, Inc. on December 18, 2013. | |
(1) Incorporated herein by reference to BioMed Realty Trust, Inc.'s Annual Report on Form 10-K filed with the Securities and Exchange Commission on February 12, 2010.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: December 18, 2013 | BIOMED REALTY TRUST, INC. | |
By: /s/ Greg N. Lubushkin | ||
Name: Greg N. Lubushkin Title: Chief Financial Officer | ||